Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Middle Mesial Canal”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Post-approval studies (Phase 4)UnknownNCT04768764
What this trial is testing

Comparison Of Femoral Block And Middle Adductor Canal Block In Patients With Knee Arthroplasty

Who this might be right for
Arthroplasty, Replacement, KneePain, PostoperativeAnesthesia and Analgesia+2 more
Bozyaka Training and Research Hospital 52
Not applicableNot Yet RecruitingNCT06978608
What this trial is testing

Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I

Who this might be right for
CRPS (Complex Regional Pain Syndrome) Type I
Azienda Ospedaliero-Universitaria Careggi 50
Not applicableStudy completedNCT03942133
What this trial is testing

Tow Techniques of Adductor Canal Block for Analgesia After Total Knee Replacement

Who this might be right for
Total Knee ArthroplastyAnalgesiaNerve Block
Peking Union Medical College Hospital 62
Not applicableLooking for participantsNCT06260618
What this trial is testing

Effect of Chitodex Gel in Tympanoplasty Surgery

Who this might be right for
Tympanic Membrane PerforationTympanic Membrane InflammationSurgery+1 more
Central Adelaide Local Health Network Incorporated 44
Not applicableNot Yet RecruitingNCT07382934
What this trial is testing

Prevalence of Radix Entomolaris and Middle Mesial Canal in an Egyptian Sub-population Using Cbct.

Who this might be right for
Radix EntomolarisMiddle Mesial Canal
Cairo University 395
Not applicableStudy completedNCT02281019
What this trial is testing

SpyGlass AMEA Registry

Who this might be right for
Biliary StrictureBiliary Obstruction Due to Common Bile Duct StonePeriampullary Tumor+1 more
Boston Scientific Corporation 526
Not applicableStudy completedNCT04489550
What this trial is testing

How Long Must the MRI Follow-up Last to Safely Identify Middle Ear Residual Cholesteatoma

Who this might be right for
Middle Ear Cholesteatoma
University Hospital, Montpellier 17
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41